Diaceutics PLC
LSE:DXRX
Diaceutics PLC
LSE:DXRX
Price:
132.5 GBX
Market Closed
Updated:
Jun 1, 2024
Diaceutics PLC
Accounts Payable
|
Diaceutics PLC
Accounts Payable Peer Comparison
Comparables:
ONT
O
ORPH
ERGO
C4XD
HVO
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Diaceutics PLC
LSE:DXRX
|
Accounts Payable
£4.2m
|
CAGR 3-Years
109%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Accounts Payable
£103.6m
|
CAGR 3-Years
50%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Accounts Payable
£2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Accounts Payable
£4.3m
|
CAGR 3-Years
23%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
C4X Discovery Holdings PLC
LSE:C4XD
|
Accounts Payable
£1.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Accounts Payable
£34.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
72%
|
CAGR 10-Years
55%
|
See Also
What is Diaceutics PLC's Accounts Payable?
Accounts Payable
4.2m
GBP
4.2m
GBP
Based on the financial report for Dec 31, 2023, Diaceutics PLC's Accounts Payable amounts to 4.2m GBP.
What is Diaceutics PLC's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
80%
80%
Over the last year, the Accounts Payable growth was 458%. The average annual Accounts Payable growth rates for Diaceutics PLC have been 109% over the past three years , 80% over the past five years .
You don't have any saved screeners yet
